Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

DERep Home Page

["Patient Characteristic, Race": "Race"]

Performance/Reporting Period
2025
Value Set Description from VSAC
Clinical Focus: n/a Data Element Scope: n/a Inclusion Criteria: n/a Exclusion Criteria: n/a

Constrained to codes in the Race value set (2.16.840.1.114222.4.11.836)

QDM Datatype and Definition

"Patient Characteristic, Race"

Data elements that meet criteria using this datatype should document the patient’s race.

Timing: Race does not have a specific timing. Measures using "Patient Characteristic, Race" should address the most recent entry in the clinical record.

eCQMs using this data element:
CMS1028v3 - Severe Obstetric Complications
CMS104v13 - Discharged on Antithrombotic Therapy
CMS1056v2 - Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Clinician Level)
CMS1074v2 - Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Facility IQR)
CMS108v13 - Venous Thromboembolism Prophylaxis
CMS1157v1 - HIV Annual Retention in Care
CMS117v13 - Childhood Immunization Status
CMS1188v2 - Sexually Transmitted Infection (STI) Testing for People with HIV
CMS1206v2 - Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Facility OQR)
CMS122v13 - Diabetes: Glycemic Status Assessment Greater Than 9%
CMS124v13 - Cervical Cancer Screening
CMS125v13 - Breast Cancer Screening
CMS128v13 - Antidepressant Medication Management
CMS129v14 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130v13 - Colorectal Cancer Screening
CMS131v13 - Diabetes: Eye Exam
CMS133v13 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS135v13 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS136v14 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS137v13 - Initiation and Engagement of Substance Use Disorder Treatment
CMS138v13 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139v13 - Falls: Screening for Future Fall Risk
CMS142v13 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS143v13 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144v13 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145v13 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)
CMS146v13 - Appropriate Testing for Pharyngitis
CMS149v13 - Dementia: Cognitive Assessment
CMS153v13 - Chlamydia Screening in Women
CMS154v13 - Appropriate Treatment for Upper Respiratory Infection (URI)
CMS155v13 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
CMS156v13 - Use of High-Risk Medications in Older Adults
CMS157v13 - Oncology: Medical and Radiation - Pain Intensity Quantified
CMS159v13 - Depression Remission at Twelve Months
CMS165v13 - Controlling High Blood Pressure
CMS177v13 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS190v13 - Intensive Care Unit Venous Thromboembolism Prophylaxis
CMS22v13 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS2v14 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS314v2 - HIV Viral Suppression
CMS334v6 - Cesarean Birth
CMS347v8 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS349v7 - HIV Screening
CMS506v7 - Safe Use of Opioids - Concurrent Prescribing
CMS50v13 - Closing the Referral Loop: Receipt of Specialist Report
CMS529v5 - Core Clinical Data Elements for the Hybrid Hospital-Wide Readmission Measure with Claims and Electronic Health Record Data - HWR
CMS56v13 - Functional Status Assessment for Total Hip Replacement
CMS645v8 - Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
CMS646v5 - Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer
CMS68v14 - Documentation of Current Medications in the Medical Record
CMS69v13 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS71v14 - Anticoagulation Therapy for Atrial Fibrillation/Flutter
CMS72v13 - Antithrombotic Therapy by End of Hospital Day 2
CMS74v14 - Primary Caries Prevention Intervention as Offered by Dentists
CMS75v13 - Children Who Have Dental Decay or Cavities
CMS771v6 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS816v4 - Hospital Harm - Severe Hypoglycemia
CMS819v3 - Hospital Harm - Opioid-Related Adverse Events
CMS826v2 - Hospital Harm - Pressure Injury
CMS832v2 - Hospital Harm - Acute Kidney Injury
CMS844v5 - Core Clinical Data Elements for the Hybrid Hospital-Wide All-Condition All-Procedure Risk-Standardized Mortality Measure - HWM
CMS871v4 - Hospital Harm - Severe Hyperglycemia
CMS90v14 - Functional Status Assessments for Heart Failure
CMS951v3 - Kidney Health Evaluation
CMS986v4 - Global Malnutrition Composite Score
CMS996v5 - Appropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department (ED)
Last Updated: Jun 26, 2024

We want your feedback

Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.